Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yanhouqing is a Traditional Chinese Medicine (TCM) hospital preparation developed by Shenzhen Longgang Central Hospital, specifically indicated for the treatment of acute pharyngitis, chronic pharyngitis, and tonsillitis. Formulated as granules for oral administration, it is composed of a proprietary blend of herbal extracts, including *Radix Isatidis* (Banlangen), *Scutellaria baicalensis* (Huangqin), and *Lonicera japonica* (Jinyinhua). The preparation functions through heat-clearing, detoxifying, and anti-inflammatory mechanisms, aimed at reducing mucosal swelling and alleviating throat pain. As a hospital-specific medicine (医院制剂), it is approved by regional regulatory authorities for clinical use within the developing institution and its medical network in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yanhouqing.